asset acquisition
Quest Diagnostics to Acquire Parts of NewYork-Presbyterian Lab Business
The company will obtain lab assets in New York City and the Tri-State Area, while NewYork-Presbyterian will continue to operate certain hospital lab services.
While reform of lab-developed test regulations and PAMA appeared possible at the beginning of 2022, in the end, the status quo won out.
ProPhase Labs to Acquire Stella Diagnostics Esophageal Cancer Screening Test for $4.5M
The agreement gives ProPhase exclusive global rights to Stella's BE-Smart Esophageal Pre-Cancer screening test and related intellectual property assets.
Quest Diagnostics Enters Lab Deal With Maine Healthcare System Northern Light Health
Quest will acquire select assets of Northern Light's outreach laboratory business and will provide management services for a number of the system's hospital labs.
Amidst industry tumult, Quest and Labcorp continue to pursue hospital lab deals as they seek to boost volumes and counter growing health system consolidation.